Cisco Systems, Inc. (CSCO)

Cisco's stock has slid 17.10% over the past month and sits in the lower half of its 52-week range, trading below its 50-day and 200-day moving averages ($108.34 and $102.04). The pullback comes after Morgan Stanley downgraded the stock to Equal-Weight from Overweight on November 5, 2026, the latest in a string of rating changes this year.

The clearest recent driver is the rating cycle. Morgan Stanley downgraded Cisco to Equal-Weight from Overweight on November 5, 2026, following HSBC's cut to Hold from Buy on August 14, 2026. Bernstein started coverage at Market Perform on September 30, 2026, and Piper Sandler kept its Neutral rating on September 22, 2026. Against that backdrop, the stock fell 8.40% in the first session after the August 12, 2026 report, even though adjusted EPS of $1.22 beat the $1.17 estimate by 4.27%. Over the past month the stock is down 17.10%, and over three months it is down 18.50%.

Profitability is strong, with a net profit margin of 20.95%, an operating margin of 27.72% and a return on equity of 27.32%, against a sector median of 13.4%. Debt-to-equity is 0.62. The earnings record is also consistent: Cisco beat the EPS estimate in all eight of the reports on record. Yet four of those eight beats were followed by a lower share price in the first session, which shows that results alone have not set the direction of the stock.

At a trailing P/E of 28.04, the stock trades 20.1% below the sector median P/E of 35.1, and its price-to-sales ratio of 6.14 is 19.2% below the sector median of 7.6. The trailing dividend yield is 1.70%, with an annual dividend of $1.67 per share. A lower multiple is consistent with the market doubting the growth rate, since revenue growth is trailing the sector. Analysts still expect EPS to rise 18.8% this fiscal year, which is the gap the valuation argument depends on.

Of 29 analysts with a current rating, 19 rate the stock buy or strong buy, 10 rate it hold and none rate it sell. Three months ago, 19 of 28 ratings were buy, so the buy count has held steady even as individual firms have trimmed their views. The median 12-month target of $135.00 is 37.5% above the price, and targets range from $110.00 to $170.00.

The base case is that the stock keeps trading in a range while it works back above its moving averages. Recovering the 200-day SMA at $102.04 and then the 20-day EMA at $104.04 would show the recent selling is losing force, and the analysts' median 12-month target of $135.00 sits well above the current price. The bearish case is a break below the 52-week low of $71.72, which would signal that the valuation discount is not attracting buyers. Analysts' estimates call for EPS to grow 18.8% this fiscal year to $5.15 and 9.3% next year to $5.62, so delivery against those numbers is the main test. Because the stock has a beta of 1.00, it is likely to follow broader market moves, and a weaker tape would make the downside more likely.

Support sits first at the 52-week low of $71.72, which is the level a fall would meet first and the lowest price in the past year. Resistance starts at the 200-day simple moving average of $102.04, the nearest level above the price and the one a rebound would test first. Next comes the 20-day exponential moving average at $104.04, then the 50-day simple moving average at $108.34, which the stock has been trading well beneath. The 52-week high of $130.37 is the furthest resistance and would require a sustained rally to reach.